https://www.selleckchem.com/pr....oducts/mitoquinone-m
2% at a median of 14 months (0-72 months). When compared with surgery, ER was associated with a lower hospitalization rate (22.2% vs 95.6%; p less then 0.0001), shorter hospital stay (mean 0.5±0.9 vs 2.23±1 days; p less then 0.0001), and fewer adverse events (5.9% vs 22.8%; p=0.0002). Intramucosal adenocarcinoma on baseline pathology (OR, 5.7; 95% CI, 1.2-28.2) and referrals by academic gastroenterologists (OR, 2.5; 95% CI, 1.11-5.72) were associated with a higher likelihood of surgery on multivariate analysis. CONCLUSIONS
Like
Comment
Share
